US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Biolife Sciences Inc
(OP:
BLFE
)
0.0001
UNCHANGED
Last Price
Updated: 12:25 PM EDT, Aug 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biolife Sciences Inc
BioLife Sciences Inc.’s (OTC: BLFE) Copper-Infused Fabric Pots Offer Investors Opportunity In $2.4 Billion US Home & Garden Market
January 18, 2023
BioLife Sciences Inc.’s (OTC: BLFE) Copper-Infused Fabric Pots Offer Investors Opportunity In $2.4 Billion US Home & Garden Market
Via
News Direct
Topics
Cannabis
BioLife Sciences Inc. (OTC:BLFE) Copper Infused Fabric Planting Pot To Disrupt Gardening Industry
December 06, 2022
BioLife Sciences Inc. (OTC:BLFE) Copper Infused Fabric Planting Pot To Disrupt Gardening Industry
Via
News Direct
Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?
August 16, 2022
By Mark Gilman - Benzinga
Via
News Direct
Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?
↗
August 15, 2022
HENDERSON, NV, Aug 10, 2022 – BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company...
Via
Benzinga
BioLife Sciences Inc. To Incorporate New Sub-Sector Dedicated To CBD
↗
March 01, 2022
BioLife Sciences (OTCPK: BLFE), a firm dedicated to developing, licensing, and distributing antimicrobial products and disruptive technologies, announced on Tuesday that it is...
Via
Benzinga